SCHEMBL6170220

SCHEMBL6170220

Cc1nc2ccc(NC(=O)OC(C)(C)C)cc2n1Cc1ccccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.55
ALDH1A1 P00352 3/20 0.55
ACSS2 Q9NR19 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
KDM4E B2RXH2 2/20 0.51
HPGD P15428 2/20 0.51
HTT P42858 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TNF P01375 2/20 0.47
PPARG P37231 1/20 0.46
NOD2 Q9HC29 1/20 0.45
NOD1 Q9Y239 1/20 0.45
BRD4 O60885 4/20 0.45
PTGES O14684 1/20 0.43
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
DHFR P00374 1/20 0.41
P2RX7 Q99572 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7653693 0.89 PPARG (0.51) MAPTALDH1A1ACSS2SMN1; SMN2KDM4E
SCHEMBL6169794 0.87 PTGES (0.57) MAPTALDH1A1ACSS2SMN1; SMN2KDM4E
SCHEMBL7712674 0.79 P2RX7 (0.48) MAPTALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL6495333 0.78 ALDH1A1 (0.44) MAPTALDH1A1ACSS2SMN1; SMN2KDM4E
SCHEMBL6497514 0.77 ALDH1A1 (0.46) MAPTALDH1A1ACSS2SMN1; SMN2KDM4E
SCHEMBL6503682 0.77 ALDH1A1 (0.43) MAPTALDH1A1ACSS2SMN1; SMN2KDM4E
SCHEMBL7649076 0.76 PPARG (0.54) MAPTALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL6169166 0.76 PPARG (0.57) MAPTALDH1A1ACSS2SMN1; SMN2KDM4E
SCHEMBL6169005 0.74 PDE2A (0.55) MAPTALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL7595767 0.74 PPARG (0.52) MAPTALDH1A1SMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6369092-B1 Method for treating neoplasia by exposure to substituted benzimidazole derivatives CELL PATHWAYS, INC. 2002-04-09 US disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed